Still on the fact that Cu-ATSM is not a PET hypoxia marker in all tumors, Vavere et al. focused on the relationship between Cu-ATSM hypoxia and fatty acid synthase (FAS) expression in prostate cancer cell lines (16). Here, FAS is linked to prostate carcinoma.